PlainPharmaWatch
CMS PY 2024 Company profile Open Payments data

AUCTA PHARMACEUTICALS, INC.

AUCTA PHARMACEUTICALS, INC. reported $25.2K in payments to physicians and teaching hospitals across 1,636 transactions in CMS Open Payments PY 2024.

Pharmaceutical payment transparency data for AUCTA PHARMACEUTICALS, INC.. Ranked #1408 of 1,797 companies by total payments. Source: CMS Open Payments, Program Year 2024.

Payment Overview

Total Payments

$25.2K

0.0% of all payments

Transactions

1,636

$15.39 avg

Recipients

1,636

$15.39 avg

Industry Rank

#1408

of 1,797 companies

What the Data Shows for AUCTA PHARMACEUTICALS, INC.

In Program Year 2024, AUCTA PHARMACEUTICALS, INC. reported $25,175.15 in payments to 1,636 physicians and teaching hospitals across 1,636 individual transactions — an average of $15.39 per transaction and $15.39 per recipient. That total places AUCTA PHARMACEUTICALS, INC. at rank #1408 out of 1,797 companies in the CMS Open Payments database, representing 0.0% of all industry payments reported nationwide for the year. Payment volume at this scale is characteristic of manufacturers with broad prescriber engagement, active clinical research programs, or patented therapies generating ongoing royalty obligations.

The payment mix for AUCTA PHARMACEUTICALS, INC. spans 2 distinct categories defined by CMS — including general payments (consulting, speaker fees, meals, travel), research payments tied to clinical trials, and ownership or investment interests. The largest single category is "Food and Beverage" at $24.0K, accounting for 95.2% of the company's reported total and 1,634 transactions. This distribution matters because different payment types carry different regulatory and ethical implications: research funding supports clinical development, while general payments like meals and speaker fees have been studied for their correlation with prescribing patterns in peer-reviewed journals such as JAMA Internal Medicine.

Recipient concentration is another useful lens. The top 5 recipients of payments from AUCTA PHARMACEUTICALS, INC. received $0.00 combined — 0.0% of the company's total — with the remaining 100.0% distributed across the rest of the 1,636 recipients. A relatively distributed top-5 share suggests broader engagement across the prescriber community rather than concentration among a handful of high-value relationships. All figures above are drawn directly from the CMS Open Payments Public Use Files for PY2024 and are disclosed under the Physician Payments Sunshine Act; this page summarizes reported financial transfers and does not represent medical advice or judgment about individual prescribing decisions.

Payment Breakdown by Type

AUCTA PHARMACEUTICALS, INC. made 2 types of payments. "Food and Beverage" accounts for 95.2%.

Food and Beverage $24.0K

95.2% · 1,634 transactions

Honoraria $1.2K

4.8% · 2 transactions

Payment Type Amount Transactions
Food and Beverage $24.0K 1,634
Honoraria $1.2K 2

Payment Size Analysis

Average transaction size: $15.39. Average per recipient: $15.39.

Total Amount

$25,175.15

Avg per Transaction

$15.39

Avg per Recipient

$15.39

Payment Transparency Context

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.3B

across 1,797 companies

AUCTA PHARMACEUTICALS, INC. Share

0.0%

#1408 by total payments

Frequently Asked Questions

How much did AUCTA PHARMACEUTICALS, INC. pay to physicians and hospitals in 2024?
AUCTA PHARMACEUTICALS, INC. made $25,175.15 in payments to physicians and hospitals in Program Year 2024, across 1,636 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from AUCTA PHARMACEUTICALS, INC.?
AUCTA PHARMACEUTICALS, INC. made payments to 1,636 physicians and teaching hospitals in 2024. The average payment per recipient was $15.39.
What types of payments did AUCTA PHARMACEUTICALS, INC. make?
AUCTA PHARMACEUTICALS, INC. made 2 different types of payments. The largest category was "Food and Beverage" at $24.0K, representing 95.2% of all payments.
How does AUCTA PHARMACEUTICALS, INC. rank among pharmaceutical companies?
AUCTA PHARMACEUTICALS, INC. ranks #1408 out of 1,797 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from AUCTA PHARMACEUTICALS, INC.?
The average transaction from AUCTA PHARMACEUTICALS, INC. was $15.39 in 2024. The company made 1,636 total transactions to 1,636 recipients.
Are the top recipients concentrated for AUCTA PHARMACEUTICALS, INC.?
The top 5 recipients received $0.00 from AUCTA PHARMACEUTICALS, INC., representing 0.0% of the company's total payments. Payments are relatively well-distributed across recipients.
Where does the payment data for AUCTA PHARMACEUTICALS, INC. come from?
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.3B across 1,797 companies.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.